A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

The parents of children with Dravet syndrome taking part in a clinical trial at Sheffield Children’s Hospital have reported ...

Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

Murdoch Children's Institute clinical science research director Dr. Vicki Anderson explains how the app will help parents and ...

Eighteen undergraduate nursing students are working as research assistants, and faculty and staff scholarly output has ...

Today, the vast majority of kids survive cancer, thanks to federally supported clinical trials, but their funding could be in ...

The results offer some of the first glimpses into real-world findings of the Janus kinase inhibitor in patients with ...

Meanwhile, William “Jamie” Tyler, Ph.D., professor and co-director of UAB’s Center for Neuroengineering and Brain Computer ...

Avacopan has been shown to work well in a real-world setting in a much broader group of people with vasculitis than was studied in the phase 3 trial that led to its approval.

Tharimmune, Inc., (Nasdaq:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology announced ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...